News
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...
In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.
New research presented May 17 at the American Psychiatric Association's Annual Meeting shows that GLP-1 receptor agonists may ...
13h
Medpage Today on MSNGLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data ShowCognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...
You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...
“Fructo-oligosaccharides (FOS) are prebiotic fibers that have a significant impact on the secretion and function of the natural hormone GLP-1, which plays a crucial role in glucose regulation, ...
20h
HealthDay on MSNGLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, DepressionFor patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is not ...
21h
The Well News on MSNFitness and Nutrition Guide to GLP-1sWASHINGTON - Many people face challenges when trying to maintain a healthy weight. Over the last few years, GLP-1 medications ...
South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...
Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...
Discover how popular GLP-1 weight loss medications like Ozempic may trigger eating disorder relapse in vulnerable users and ...
Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results